throbber
Biochemistry 1988, 27, 4639-4645
`
`4639
`
`Fluorescence Indicates a Calcium-Dependent Interaction between the Lipopeptide
`Antibiotic LY 146032 and Phospholipid Membranes
`
`Jeremy H. Lakey* and Marius Ptak
`Centre de Biophysique MolZculaire, CNRS, and UniversitZ dOrlZans, I A, Avenue de la Recherche Scientifique, 45071 Orleans
`Cgdex 2, France
`Received June 15, 1987; Revised Manuscript Received January 21, 1988
`
`ABSTRACT: LY 146032 is one of the A21978C family of calcium-dependent antibiotics. This paper reports
`on its interactions with membranes as studied by its intrinsic fluorescence. The Trp residue was found to
`have a low fluorescence yield because of Forster-type energy transfer to the kynurenine residue (Kyn) ( E
`= 465 nm in HzO) was a sensitive probe of the
`= 5000 a t 364 nm). However, the Kyn fluorescence (A,,,
`membrane interactions, and it was used in steady-state fluorescence measurements including fluorescence
`polarization anisotropy. Initial binding of the peptide to phospholipid vesicles occurs in calcium-free solutions.
`When calcium is added, the resulting 10-fold fluorescent enhancement and 15-nm blue shift show that it
`causes the antibiotic to penetrate further into the lipid bilayer. Calcium is bound with an association constant
`of 151 M-l, while a phospholipid titration in the presence of calcium gave an association constant of 5 X
`1 O3 M-' for egg phosphatidylcholine. Magnesium and cadmium cause very slight fluorescence enhancements,
`but a more significant effect is caused by the trivalent lanthanide ions. Analysis of these data indicates
`that the calcium-selective site is on the peptide and that ion binding to the phospholipid headgroups has
`a secondary role. Comparison with the divalent cation dependent antibiotics bacitracin and amphomycin
`shows that LY 146032 has a quite different activity and that a calcium-dependent membrane interaction
`could account for results obtained in vivo.
`
`L Y 146032 (Figure l), an acidic lipopeptide antibiotic
`produced by Streptomyces roseosporus, is effective against
`a range of Gram-positive pathogenic bacteria (Eliopolous et
`al., 1985). However, its in vitro antibiotic activity is unusual
`because it requires the presence of calcium ions. For example,
`it has been shown that in the case of Streptococcus faecalis
`the addition of 1 mM calcium chloride to the culture medium
`causes a 30-fold decrease in the minimum inhibitory concen-
`tration (Eliopolous et al., 1985). This effect was found to be
`unique to calcium, and media supplements of Ba2+, Zn2+ and
`Mg2+ had no comparable ability to lower the minimum in-
`hibitory concentration. LY146032 has been shown to inhibit
`test infections in mice, but clearly it was not possible to observe
`the effect of a varying Ca2+ concentration.
`The possibility that its action was that of a calcium iono-
`phore was excluded by experiments on black lipid films and
`phospholipid vesicles. These showed that although it did in-
`crease the bilayer conductivity, this increase was neither
`calcium dependent nor sufficiently large to account for the
`observed antibacterial activity (Lakey & Lea, 1986). These
`experiments did show, however, that in common with other
`lipopeptides, e.g., polymixins, octapeptins (Storm et al., 1977),
`and iturins (Maget-Dana et al., 1985), LY146032 interacts
`strongly with bilayer membranes (Lakey & Lea, 1986). This
`common property of lipopeptides is thought to be due to in-
`sertion of the fatty acyl moiety into the membrane, and as a
`group their modes of action are varied but always membrane
`based. If the action of LY146032 involves a membrane-based
`step, it serves a purpose other than directly increasing mem-
`brane permeability, and so another measure of this interaction
`
`is required. In this paper we use the intrinsic fluorescence of
`LY 146032 to study its interactions with phospholipid vesicles
`and calcium.
`The peptide sequence of LY 146032 is identical with that
`of the A21978C family of peptides produced by S. roseosporus
`(Debono et al., 1987). They differ solely in the length of their
`fatty acyl tails, LY 146032 having a straight-chain decanoyl
`side chain (Figure 1). As the chemical structure of the cal-
`cium-dependent antibiotic (CDA) from Streptomyces coeli-
`color (Lakey et al., 1983) is unknown, its relationship with
`LY146032 is unclear.
`
`EXPERIMENTAL PROCEDURES
`LY146032 was a gift from Lawrence Day of Eli Lilly &
`Co. Egg yolk phosphatidylcholine was purified according to
`the method of Singleton et al. (1965). DMPC' and DPPC
`were purchased from Sigma, verified pure by thin-layer
`chromatography, and used without further purification. GdC13
`was from UCB, Brussels, Belgium, and EuC1, was from Fluka.
`L-Kyn was purchased from Sigma, and all other chemicals
`were of the best available grade.
`Small unilamellar vesicles (SUV) were prepared by soni-
`cation. Phospholipid in ethanol was dried as a thin film in a
`glass cup, a standard buffer solution (standard buffer, 200 mM
`KCl/10 mM cacodylate, pH 6.0) was added, and sonication
`by an MSE sonicator was carried out under nitrogen. Sub-
`sequently, the vesicles were centrifuged for 1 h at 40 000 rpm
`(1 30000g) to remove multilamellar liposomes and titanium
`fragments. All stages of the preparation were performed above
`the phase transition temperature for the lipid concerned. PC
`
`*Address correspondence to J.H.L. at the European Molecular Bi-
`ology Laboratory, Meyerhofstrasse, Postfach 10.2209, D-6900 Heidel-
`berg, FRG. J.H.L. Thanks the Science and Engineering Research
`Council (Swindon, U.K.) for the award of a NATO postdoctoral fel-
`lowship.
`
`Abbreviations: SUV, small unilamellar vesicles; PC, phosphatidyl-
`choline; DMPC, L-a-dimyristoyl-PC; DPPC, L-a-dipalmitoyl-PC; L-Kyn,
`free kynurenine; P-Kyn, kynurenine residue in LY 146032; FPA,
`fluorescence polarization anisotropy; T,, phase transition temperature.
`
`0006-2960/88/0427-4639$01.50/0
`
`0 1988 American Chemical Society
`
`
`1 of 7
`
`FRESENIUS-KABI, Exh. 1033
`
`

`
`4640 B I O C H E M I S T R Y
`
`L A K E Y A N D P T A K
`
`t
`L - O r n
`f
`
`"'y,
`
`L - A S P
`N
`*
`D - A l a
`f
`L -Asp
`
`
`G ~ Y
`\
`D - Ser
`I
`(L - threo) 3 - MeGlu
`1
`L - Kyn
`.oAo
`
`L - Thr
`t
`t
`L - A S P
`L - A m
`t
`L -Trp
`I
`NH
`
`FIGURE 1: Structure of LY146032 (decanoyLA21978C): Kyn, ky-
`nurenine; Orn, ornithine; Me-Glu, methyl glutamate.
`
`concentrations were determined by measuring the lipid
`phosphorus according to the method of Chen et al. (1956).
`Chemical Modification of LY146032. Acetylation of the
`aromatic amine on the kynurenine residue of LY146032 was
`carried out as follows: 0.5 mg of LY146032 was dissolved in
`a solution of 330 pL of distilled water, 100 pL of 1 M HCl,
`and 60 p L of acetic anhydride by vortexing. After the addition
`of 20 mg of solid sodium acetate, the mixture was vortexed
`again and then purified by the method of Bohlen et al. (1980)
`with 2-propanol/water (7/1) as the eluant.
`Fluorescence Techniques. Fluorescence measurements were
`carried out on a Kontron SFM25 with slits set to 5 nm (ex-
`citation) and 10 nm (emission). The spectrofluorometer was
`interfaced with an Apple IIe microcomputer for data collection
`and manipulation. Temperature control was by circulating
`water through the four-cell holder in which the temperature
`was measured by a thermocouple placed in a buffer-filled
`cuvette.
`The fluorescence results are expressed as either the relative
`fluorescence at a given wavelength (F) or, where possible, the
`relative quantum yield (@) calculated as the integrated
`fluorescence emission between 400 and 520 nm.
`Polarization experiments used the SFM25 polarization
`accessory under remote control via the Apple IIe. The
`fluorescence intensity components (Iw, Ivh, Ihv, Ihh), in which
`the subscripts refer to the horizontal (h) or vertical (v) pos-
`itioning of the excitation and emission polarizers, respectively,
`were used to calculate the steady-state fluorescence polari-
`zation anisotropy (FPA):
`FPA = ( I , - IvhG)/(zw + 21,hG)
`(1)
`where G is the grating factor that corrects for wavelength-
`dependent distortions of the polarizing system.
`(2)
`= I h v / I h h
`All experiments were carried out in 1 cm path length cu-
`vettes containing at least 2.5 mL of sample with an absorption
`at 364 nm of <0.1. Absorption measurements were performed
`on a Beckman DU-8 or an LKB Biochrom spectrometer.
`The association of LY 146032 with phosphatidylcholine,
`Ca2+, and Gd3+ (as ligands) was analyzed by the method of
`Lehrer and Fasman (1966). The association constant K, is
`related to the sample fluorescence at a particular ligand
`concentration [SI by
`Ka = [ ( F - F o ) / ( F ~ - F)I(l/[sI)
`(3)
`where the fluorescence intensities of the peptide alone, the
`peptide at [SI, and the peptide at an infinite concentration of
`S are denoted by Fo, F, and F,, respectively. F, was calculated
`
`FIGURE 2: Absorption spectra of native and modified LY146032 in
`water: solid line, unmodified LY146032; broken line, LY146032 after
`acetylation of its kynurenine residue.
`I
`I
`
`c l
`
`
`
`, n
`
`I
`I
`
`I
`
`Excitation wavelength
`FIGURE 3: Excitation spectra of LY 146032 kynurenine fluorescence
`in 1 mg/mL egg PC SW: F(450 nm), relative fluorescence at 450-nm
`emission wavelength without subtraction of the SUV base line; (-)
`standard buffer plus 50 mM CaCI,; (- - -) standard buffer plus 50
`mM CaCl, and 15 mM GdC13. The excitation spectrum of free t-Kyn
`in standard buffer is also shown (--) although not on the same scale.
`by extrapolation of the plot 1/(F - Fo) versus 1 /[SI to 1 /[SI
`= 0. In all cases, the plot of (F - Fo)/(Fm - F) versus [SI fitted
`to a straight line at nonsaturation concentrations of S , and Ka
`was calculated as the inverse of [SI at the intersection with
`(F - Fo)/(F.. - F) = 1 (Privat et al., 1974). The treatments
`according to Kolber and Haynes (1981) and Kauffman et al.
`(1983) were as described in the original references.
`
`RESULTS
`As shown in
`LYI 46032 Fluorescence Characteristics.
`Figure 1, the peptide contains four negatively charged groups
`[three aspartate and one methyl glutamate (Me-Glu)], one
`positively charged ornithine (Orn), and two fluorophores.
`These comprise a tryptophan residue situated between the lipid
`chain and the peptide headgroup and a kynurenine residue
`(Kyn) in the headgroup itself. The situation of the Trp should
`make it sensitive to insertion of the lipid moiety into a hy-
`drophobic bilayer, but unfortunately, this residue has a very
`poor fluorescence yield. When a solution of LY146032
`M peptide in standard buffer) was excited at 285 nm, the Trp
`emission was only 3.5% that of free L-Trp under the same
`conditions. The absorption spectrum clearly indicates (Figure
`2) a Trp (e = 5000 at 286 nm) concentration equal to that
`of the peptide, while the 'H NMR spectrum (D. Marion, A.
`Caille, J. Lakey, and M. Ptak, unpublished results) showed
`Trp and kynurenine to be present in equal proportions, thus
`excluding the possibility of Trp degradation having occurred
`(Creed, 1984). Furthermore, the excitation at 285 nm pro-
`duced a second emission at 465 nm, which was more intense
`when excited at 365 nm, indicating that Kyn was the second
`emission source. The excitation spectrum (Figure 3) for this
`Kyn emission clearly shows a strong Trp component around
`285 nm that is in between the Kyn absorbtion maxima at 256
`and 364 nm. It was thus assumed that the poor Trp emission
`is at least partly due to energy transfer. This Forster type of
`transfer results from the combination of the proximity of the
`two fluorophores and the overlap of the Trp emission spectrum
`
`
`2 of 7
`
`

`
`C A L C I U M - D E P E N D E N T A N T I B I O T I C L Y 1 4 6 0 3 2
`
`V O L . 2 7 , N O . 1 3 , 1 9 8 8 4641
`
`salt
`
`concn
`(mM)
`
`Table I: Effect of Multivalent Ions on P-Kyn Fluorescence
`re1
`quantum
`yield
`1
`0.80
`0.92
`0.98
`2.62
`1 .o
`10.7
`1.7
`1.2
`5.4
`
`LY 146032
`M in std buffer) CaC12
`CdC12
`MgCI2
`GdCIS
`LY 146032
`( M + 1 mg/mL CaCI2
`egg PC in std
`CdCl2
`buffer)
`MgC12
`GdClq
`
`50
`50
`50
`15
`
`50
`50
`50
`5
`
`max
`emission
`(nm)
`465
`465
`465
`46 5
`456
`462
`450
`462
`462
`452
`
`l b
`
`" T 0
`
`4b 50
`30
`20
`[Ca"]/mM
`FIGURE 5: LY 146032 kynurenine fluorescence enhancement in
`phosphatidylcholine SUVs by calcium ions. Samples contained 1
`mg/mL egg PC SUV and
`M LY146032 in standard buffer.
`Calcium was added from 1 or 3 M CaC1, stock solution and mixed,
`and the fluorescence yield was measured as the integral between 400
`and 520 nm after base line subtraction. The fluorescence increase
`was instantaneous on this time scale. A,,,, wavelength of maximum
`emission; 4, fluorescence yield; &, fluorescence yield in the absence
`of multivalent ions; A,,,
`365 nm.
`
`[Gd3+ I/ mM
`FIGURE 6: Fluorescence and light scattering increases in LY146032
`solution on GdCl, addition. ( 0 ) Fluorescence expressed as the fraction
`of maximum fluorescence attained (FIF,). The cuvette contained
`M LY146032 in standard buffer. Gd3+ was added
`2.5 mL of
`from 0.5 M GdC13 stock. A,,,
`365 nm; A,,,
`455 nm. (A) Same
`conditions as above except that A,, = A,,
`= 480 nm so that the
`measured signal is a product of the solution's light scattering properties.
`The increases were not immediate, and those plotted (S and F) are
`the values 30 min after Gd3+ addition.
`P-Kyn emission combined with a blue shift in its maximum
`(Table I; Figures 4 and 5). The effect was the same when
`calcium acetate was used instead. The order of size of effect
`was again Ca2+ >> Cd2+ > Mg2+ (Table I).
`Effect of Lanthanide Ions. When their use as possible
`quenching agents was investigated, it was discovered that the
`lanthanide ions Eu3+ and Gd3+ also showed very specific in-
`teractions with LY146032. As shown in Table I, GdCl, has
`the opposite effect to CaCl, on the free peptide, causing an
`increase in P-Kyn's relative quantum yield. When followed
`simultaneously by light scattering measurements, the
`fluorescence increase was seen to be accompanied by the
`formation of aggregates (Figure 6), which may render P-Kyn
`into a more hydrophobic environment. At saturating con-
`centrations, in egg PC SUV, GdCl, and EuCI, cause smaller
`increases and blue shifts in P-Kyn emission than does CaC1,
`(Table I; Figure 7). If GdC1, is added to
`M LY146032,
`1 mg/mL egg PC, and 50 mM CaCl,, the fluorescence in-
`creases again with a second saturation at 5 mM GdCl, (Figure
`3). A like result is obtained when calcium ions are added to
`a suspension containing 15 mM GdCl,. Thus, it appears that
`the action of one species does not impede the activity of the
`other.
`The data from Figures 5 and 7, when analyzed as described
`earlier, gave association constants (K,) for the Ca2+ and Gd3+
`effects as 151 M-' and 6.6 X lo3 M-I, respectively. This
`assumes that the fluorescence enhancement is proportional to
`the quantity of bound ion.
`
`F
`
`400
`
`Emission wavelength
`FIGURE 4: Emission spectra of LY 146032 kynurenine fluorescence
`in 1 mg/mL egg PC SUV. F is the relative fluorescence after sub-
`traction of the SUV base line. Spectra show the increase in
`fluorescence as the calcium ion concentration is increased stepwise
`from 0 to 10 mM CaCI2 in standard buffer. Excitation wavelength,
`365 nm.
`
`and Kyn absorption spectrum (Weinryb & Steiner, 1971).
`Chemical Modification of Kyn. In order to test this hy-
`pothesis and perhaps in so doing increase the available Trp
`signal, we changed the absorption characteristics of the Kyn
`residue by acetylation of the free NHz group. This resulted
`in a decrease in the Kyn absorbance (Figure 2), which together
`with the Kyn fluorescence was blue shifted by 20 nm. As the
`Kyn absorption band was initially at a longer wavelength
`( ~ 3 6 0 nm) than the Trp emission (-350 nm), this shift alters
`only slightly the overlap of these two functions. However, the
`combined changes in the Kyn absorption result in a 25% in-
`crease in the Trp emission, which although confirming the
`energy-transfer hypothesis does little to enhance Trp's use-
`fulness for studies in vesicles. Other modifications (carba-
`mylation, benzoylation) were tried, but acetylation proved the
`most effective. All subsequent experiments were carried out
`on the unmodified peptide.
`Kynurenine Fluorescence. Kyn shows only a very weak
`fluorescence as a free amino acid (L-Kyn), but when incor-
`porated into the peptide (P-Kyn), its relative quantum yield
`is 7.6 times greater. As such it is slightly more luminescent
`than P-Trp at
`M, although at higher peptide concentra-
`tions the ratio of fluorescence yield P-Kyn/P-Trp increases,
`possibly due to aggregation effects (IH NMR in water at pH
`6.0 reveals significant line broadening above 5 mM peptide).
`In 1 mg/mL egg PC vesicles the P-Kyn
`M) yield in-
`creases by 2.5-fold and thus becomes useable in studies of
`lipopeptide/vesicle binding. This is further helped by the
`>80-nm difference in its absorption and emission wavelengths,
`which reduces problems due to vesicle light scattering.
`Effect of Calcium Ions. When added to the free peptide
`in solution, divalent cations reduced the P-Kyn fluorescence,
`and the size of this quenching diminished in the order Ca2+
`>> Cd2+ > Mgz+ (Table I). There was no observable effect
`on the wavelength of maximum emission, the absorption
`spectrum, or the extent of aggregation as viewed by light
`scattering. When mixed with egg PC vesicles, the result is
`the reverse with 50 mM CaCl,, causing a 10-fold increase in
`
`
`3 of 7
`
`

`
`4642 B I O C H E M I S T R Y
`
`4 6 0 J
`
`5 T
`
`0
`
`1
`
`5
`
`
`
`4
`3
`2
`[Gdfl/mM
`FIGURE 7: LY 146032 kynurenine fluorescence enhancement in
`phosphatidylcholine SUVs by gadolinium ions. Samples contained
`M LY146032 in standard buffer.
`1 mg/mL egg PC SUV and
`Gadolinium was added from 0.5 M GdCI3 stock solutions and mixed,
`and the resultant mixture was analyzed as in Figure 5. The
`fluorescence increase was instantaneous on this time scale.
`
`FIGURE 8: Influence of surface charge on LY146032 kynurenine
`fluorescence enhancement in phosphatidylcholine SUVs by calcium
`ions: ( 0 ) 2.5 mL of 1 mg/mL egg PC SUV and M LY146032
`in standard buffer; (A) 2.5 mL of 1 mg/mL egg PC/stearylamine
`(9:l) SUV and
`M LY146032 in standard buffer; (B) 2.5 mL
`of 1 mg/mL egp PC/PI (9:l) SUV and lV5 M LY146032 in standard
`buffer. For other details see Figure 5 .
`The influence that surface charge has on the Ca2+ effect
`is indicated in Figure 8, which shows the results of adding a
`10% mole fraction of phosphatidylinositol (PI) or stearylamine
`(ST) to the egg PC used to make the vesicles. The presence
`of negative charges (PI) reduces the response to Ca2+ addition,
`and the form of the curve is changed, with no observed satu-
`ration below 50 mM. The enhancement in positively charged
`bilayers is greater than in PC alone. The initial value of F
`has been normalized to 1 in all cases, and so differences due
`to charge in the absence of Ca have been ignored. On average
`(four experiments), the P-Kyn fluorescence at zero Ca2+ in
`negative bilayers was 88% that of the positive preparations.
`Gadolinium chloride was similarly affected by the charges,
`and its supplementary increase of P-Kyn emission in 50 mM
`CaCl, remained.
`As the P-Kyn yield is dependent upon both Ca2+ and PC,
`it is important to consider whether the peptides' affinity for
`PC is calcium dependent. In this respect it is possible to
`measure an association constant between fluorophores and
`membranes by fluorometric titration of the molecule in solution
`with phospholipid vesicles (Kauffman et al., 1983; Kolber &
`Haynes, 1981). The data shown in Figure 9 were analyzed,
`like the ion binding data, according to the method of Lehrer
`and Fasman (1966), and this gave a K , of 5.0 X lo3 M-'
`[application of the analogous method of Kauffman et al.
`(1983) and Kolber and Haynes (1981) gave results within 0.3
`X lo3 M-'1. Unfortunately, however, a comparison with the
`binding of PC in the absence of Ca2+ proved to be impossible
`due to the feeble fluorescence enhancement involved.
`
`L A K E Y A N D P T A K
`
`0.3
`
`FIGURE 9: Effect of phosphatidylcholine and calcium ion titrations
`on LY 146032 kynurenine fluorescence emission and fluorescence
`polarization anisotropy (FPA). DMPC titration (left-hand figure):
`(m) fluorescence increase (F) of
`M LY 146032 in standard buffer
`plus 50 mM CaCI, on addition of aliquots of 10.4 mg/mL DMPC
`SUV, M LY146032, and 50 mM CaCI2 in standard buffer; (0)
`FPA increase under the same conditions. Calcium titration (right-hand
`M LY146032 in standard
`figure): (B) fluorescence increase of
`buffer plus 0.83 mg/mL DMPC on addition of aliquots of 3 M CaCI,;
`(0) FPA under the same conditions. For calculation of FPA, see text;
`T = 30 OC.
`
`Io
`
`1 0
`
`fC
`
`FIGURE 10: Dependence of LY 146032 kynurenine fluorescence on
`lipid-phase transition. All samples contained lo-' M LY146032. Top:
`1 mg/mL egg PC SUV and 50 mM CaC1, in standard buffer. Middle:
`1 mg/mL DMPC SUV and 50 mM CaC12 in standard buffer. Bottom:
`1 mg/mL DMPC SUV in standard buffer (Le., no calcium). Results
`are from temperature increases (10-50 "C) only.
`
`In order to gain some insight into the role of Ca2+ in
`LY 146032/PC binding, we carried out measurements of
`fluorescence polarization anisotropy (FPA). In 50 mM CaC12,
`P-Kyn shows a rise in FPA when PC is added that parallels
`the increase in P-Kyn emission (Figure 9). This indicates that
`the move of P-Kyn into a hydrophobic environment is asso-
`ciated with attachment to a larger structure, i.e., the phos-
`pholipid vesicle. At zero calcium, the FPA of LY146032 in
`1 mg/mL PC is already at the maximum value of 0.30 reached
`in the PC titration. This confirms that the peptide is already
`fixed to the vesicles. An addition of Ca2+ causes an increase
`of the P-Kyn emission (Figure 9), which suggests a change
`in its environment but does not modify its FPA.
`The interaction of LY146032 and PC was also followed as
`a function of temperature (Figure 10). In egg PC vesicles
`(50 mM CaC1,) the fluorescence yield fell smoothly with
`increasing temperature due to greater nonradiative energy
`losses. This fall was, however, less than in aqueous solution
`due to the protective shielding of the lipid bilayer. In DMPC
`bilayers (50 mM CaCl,) the fluorescence falls steadily until
`21 OC when it rapidly increases to a value at 26 OC that is
`greater than its yield at 10 OC. It then drops almost linearly.
`In the absence of Ca2+ the P-Kyn yield drops as though in
`aqueous solution, with only a slight flattening of the curve
`around 21 OC.
`If DPPC bilayers are substituted, the
`fluorescence shows a rapid increase between 39 and 45 OC
`
`
`4 of 7
`
`

`
`C A L C I U M - D E P E N D E N T A N T I B I O T I C L Y 1 4 6 0 3 2
`
`(data not shown), while similar results were obtained from
`samples containing gadolinium ions rather than calcium ions.
`The increase in yield is thus associated directly with the
`"melting" of the lipid chains that occurs at the phase transition
`temperature (T,) of the lipid in SUV [T,(egg PC) < 0 OC;
`T,(DMPC) = 20.8 OC (Gaber & Sheridan, 1982); T,(DPPC)
`= 38 OC (Suurkuursk et al., 1976)l. Hence, in the absence
`of calcium the P-Kyn residues bound to SUVs are largely
`unaffected by the gel to liquid-crystalline transition of the fatty
`acyl chains. Whereas when calcium is present, it is clear that
`the P-Kyn fluorophore is very much more sensitive to the state
`of the hydrocarbon interior of the bilayer.
`DISCUSSION
`The results presented in this paper clearly demonstrate that
`there is a calcium-dependent interaction between LY 146032
`and phospholipid vesicles that may aid our understanding of
`this antibiotic's in vivo calcium requirement.
`In all the experiments described here we can assume that
`the lipopeptide is in monomer form. However, our 'H NMR
`studies have shown that aggregation does occur at concen-
`M. When mixed with SUV in the
`trations higher than
`absence of CaC12, the P-Kyn yield is seen to increase by
`2.5-fold, and the FPA study confirmed that the peptide does
`not require calcium in order to bind to these model membranes.
`The molecule is presumably anchored to phospholipid bilayers
`by insertion of its fatty acyl moiety into the nonpolar hydro-
`carbon layer. The existence of both negative and positive
`charges on the LY 146032 headgroup should not be overlooked,
`and electrostatic interactions may also be involved at this stage.
`The high value of the FPA (0.30) indicates that the mobility
`of the P-Kyn residue is very restricted. However, the small
`change in the emission wavelength, the marked temperature
`dependence, and the insensitivity to the lipid phase transition
`all show that, while the peptide is certainly adhering to the
`membrane, this residue is situated at the lipid-water interface
`and is still accessible to the solvent. When calcium ions are
`added to the peptide/vesicle suspension, the blue shift of 10
`nm and increase in relative quantum yield show that the PO-
`larity of the environment around P-Kyn falls considerably.
`This suggests that the neutralization of the peptide induces
`a motion toward the bilayer interior in which the P-Kyn comes
`in closer contact with the hydrocarbon chains. That such a
`change occurs is confirmed by the closely related yield en-
`hancement that occurs on the melting of these chains at T,.
`The change in the position of the peptide caused by CaZf
`binding does not modify the FPA of its P-Kyn residue. Let
`us recall that, for a simple spherical molecule, the FPA is given
`by the classical Perrin equation
`FPA = 0.40[1/(1 + T/O)]
`where 7 is the fluorescence lifetime and 0 the rotation corre-
`lation time. Usually, the major causes of FPA variations are
`changes in the correlation time 0.
`In the present case, a FPA of 0.30 found in the absence of
`calcium indicates that the fluorescent probe linked to a slowly
`rotating vesicle already has a very restricted residual motion.
`A penetration of the peptide in the bilayer induced by CaZ+
`could still slightly reduce this motion, but at the same time,
`there is an increase in the fluorescence lifetime (7) that could
`compensate for an increase in 0. Qualitatively, one can only
`state that the change in the position of the peptide modifies
`the fluorescence parameters of P-Kyn in a manner that
`maintains the FPA nearly constant.
`In fact, the P-Kyn residue probably has several lifetimes
`T~ and several correlation times 01, depending on its motions
`
`V O L . 2 1 , N O . 1 3 , 1 9 8 8 4643
`on the peptide cycle and in the bilayer environment. The
`binding of Ca*+, which affects the conformation of the peptide
`and its position, modified the values and the distribution of
`such fluorescence parameters in a complex manner, which
`cannot be determined only by static measurements of an-
`isotropy. Measurements of all lifetimes and anisotropies are
`then required and should be the next step of the present study.
`In these experiments calcium ions can interact with two
`classes of site, (a) the negatively charged groups of the lipo-
`peptide and (b) the zwitterionic groups of phosphatidylcholine.
`Calcium does bind to pure phosphatidylcholine bilayers and
`induce changes in organization that can be monitored by a
`variety of techniques [for a review, see Altenbach and Seelig
`(1984)l. Such studies indicate that the binding is weak (1-100
`M-l) and that it provokes a rigidification of the bilayer
`(Chapman et al., 1977) and establishes a positive surface
`potential on these zwitterionic bilayers (Altenbach & Seelig,
`1984; Shah & Schulman, 1965). Much greater Ca2+ inter-
`actions are seen on negatively charged films. This is most
`apparent at low calcium concentrations, where the originally
`negative surface potential is rapidly neutralized. However,
`the Ca2+ ions do not bind directly to individual lipids but lie
`in the membrane potential trough with their effects shared
`among all the surface components (Macdonald & Seelig,
`1987). The degree of selectivity between Ca2+, CdZ+, and
`Mgz+ manifested by LY146032 is not shown by pure PC
`systems alone (Chapman, 1977), while the Ca2+ >> Cd2+ >
`Mg2+ order of both solution quenching and membrane en-
`hancement points to the peptide's involvement in the binding.
`The association constant for calcium is outside the range
`quoted for Ca-PC binding, but it should be made clear here
`that all the K, values are first approximations only and use
`bulk solution concentrations rather than those existing in the
`double layer. Nevertheless, the binding constant is independent
`of the peptide concentration (results not shown) and is
`therefore a genuine feature of this lipid-peptide interaction
`rather than a function of the number of peptides per unit area
`of membrane.
`The role of CaZf in the membrane interaction is clarified
`by the experiments with Gd3+. It is known from previous
`studies (Akutsu & Seelig, 1981; Hauser et al., 1975) that Gd3+
`interacts more strongly with phospholipids than does calcium,
`and this has been shown to be due to close association of the
`trivalent lanthanides with the phosphate group of the lipid
`headgroup (Hauser et al., 1975).
`Hence, the fluorescence enhancement induced by Gd3+ in
`SUVs already saturated with Ca2+ is to be expected as the
`trivalent ions will replace the divalent calcium at the interface.
`However, this means that the fluorescence enhancement that
`occurs when Ca2+ is added to a Gd3+-saturated sample must
`be due to the existence of a site that is selective for Ca2+ over
`Gd3+. Our knowledge of the phospholipid headgroup pref-
`erence for gadolinium thus confirms that a calcium-selective
`site must exist on the peptide.
`The aggregation of LY146032 in free solution by gadoli-
`nium ions does indicate a degree of direct association that is
`not entirely unexpected between two such species. The rele-
`vance of this result to the membrane effect is however not yet
`clear.
`At this stage it is reasonable to propose a model for the
`observed fluorescence changes in which the peptide, initially
`bound to the membrane by its lipid tail, is drawn further into
`the membrane by calcium bound to its negative residues and
`calcium associated with the neighboring phospholipid interface.
`Such a peptide will provoke a localized negative potential that
`
`
`5 of 7
`
`

`
`4644 B I O C H E M I S T R Y
`
`loosely associated CaZ+ will neutralize. When in competition
`with Gd3+, these will be replaced, and only the tightly bound
`calcium ion(s) will remain. This may explain the slight sig-
`moidal nature of the Ca2+ titration curve with the peptides
`high-affinity binding site effective in the 0-2 mM range and
`the phospholipid binding saturating at 30 mM. Unfortunately,
`the induced fluorescence enhancement does not allow a serious
`analysis of this region, and the calculated binding constants
`assume one type of site. The proposed role for the lipid
`phosphate groups may also explain why LY 146032 is less
`effective in increasing the conductivity of bilayer lipid mem-
`brane (BLM) formed from nonphospholipids (Lakey & Lea,
`1986).
`In the presence of negatively charged lipids, localized neg-
`ative potentials will not be effective in obtaining the calcium
`ions necessary for charge neutralization and the membrane
`penetration will be lessened as seen under Results. The effect
`of cationic lipids may therefore be explained as an enhance-
`ment of the local negative potential well around the peptide.
`Further study is required on the role of the positively
`charged ornithine in these experiments. It may be neutralized
`by a close union with one of the negative residues, but if free,
`it could possibly play an important role in the more electro-
`statically neutral calcium/peptide complex.
`Polymixin, a positively charged lipopeptide antibiotic, might
`be expected to show binding to the phosphates of zwitterionic
`phospholipids but instead is entirely dependent on negatively
`charged lipids for its membrane binding (Hartmann et al.,
`1977). Its lipid chain does enter the membrane (Hartmann
`et al., 1977), but the charge interaction is less specific than
`LY 146032 in which a positive membrane surface charge
`cannot replace calcium.
`Two other calcium-sensitive acidic peptide antibiotics are
`known, bacitracin (Stone & Strominger, 1971) and ampho-
`mycin (Matsui et al., 1963). Bacitracin, a cyclic peptide with
`one Asp residue, is in fact sensitive to a range of divalent
`cations (Mg2+, Ca2+, Cu2+, Zn2+; Stone & Strominger, 1971).
`It has been shown to inhibi

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket